Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y019465 | — |
No symptomatic adverse events were reported. No additional information is available. No additional AE; HCP called to report that the patient inadvertently received an extra dose of PROQUAD.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-APR-2025, the patient was inadvertently vaccinated with an extra dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection, 0.5 milliliters (mL), lot #Y019465; which has been verified to be valid for of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live, with an expiration date reported and establish as 24-MAY-2026, administered for prophylaxis (strength, route and anatomical site of administration were not provided), with the sterile diluent (BAXTER STERILE DILUENT), lot #1973306; which has been verified to be valid, with an expiration date reported and establish as 30-OCT-2026 (Extra dose administered). No symptomatic adverse events were reported (No adverse event).
DILUENT MERCK